These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32 related articles for article (PubMed ID: 10811985)
21. [Molecular mechanism of hepatocarcinogenesis]. Imazeki F; Saisho H Gan To Kagaku Ryoho; 1999 Dec; 26(14):2154-61. PubMed ID: 10635298 [TBL] [Abstract][Full Text] [Related]
22. Genetics of hepatocellular carcinoma. Buendia MA Semin Cancer Biol; 2000 Jun; 10(3):185-200. PubMed ID: 10936068 [TBL] [Abstract][Full Text] [Related]
23. Multistep hepatocarcinogenesis in transgenic mice harboring SV40 T-antigen gene. Kitagawa T; Hino O; Lee GH; Li H; Liu J; Nomura K; Ohtake K; Furuta Y; Aizawa S Princess Takamatsu Symp; 1991; 22():349-60. PubMed ID: 1668891 [TBL] [Abstract][Full Text] [Related]
24. Focus on hepatocellular carcinoma. Bruix J; Boix L; Sala M; Llovet JM Cancer Cell; 2004 Mar; 5(3):215-9. PubMed ID: 15050913 [No Abstract] [Full Text] [Related]
25. beta-catenin mutations are absent in hepatocellular carcinomas of SV40 T-antigen transgenic mice. Umeda T; Yamamoto T; Kajino K; Hino O Int J Oncol; 2000 Jun; 16(6):1133-6. PubMed ID: 10811985 [TBL] [Abstract][Full Text] [Related]
26. Overview of the molecular biology of hepatocellular neoplasms and hepatoblastomas of the mouse liver. Kim Y; Sills RC; Houle CD Toxicol Pathol; 2005; 33(1):175-80. PubMed ID: 15805069 [TBL] [Abstract][Full Text] [Related]
28. Truncated form of beta-catenin and reduced expression of wild-type catenins feature HepG2 human liver cancer cells. Carruba G; Cervello M; Miceli MD; Farruggio R; Notarbartolo M; Virruso L; Giannitrapani L; Gambino R; Montalto G; Castagnetta L Ann N Y Acad Sci; 1999; 886():212-6. PubMed ID: 10667222 [No Abstract] [Full Text] [Related]
30. Genetic alterations in hepatoblastoma and hepatocellular carcinoma: common and distinctive aspects. Buendia MA Med Pediatr Oncol; 2002 Nov; 39(5):530-5. PubMed ID: 12228912 [TBL] [Abstract][Full Text] [Related]